Importantly, we found that higher RBMS1 expression level was significantly correlated with clinical stage (P = 0.0491) and lymph node metastasis (P = 0.028) in lung cancer patients, but not with other factors, including sex, age, and tumor size (Table 1). Here, RBMS1 is linked to metastatic malignant neoplasm in the lymph nodes.